| For: | Ji Y, Liu RX, He PY, Zhou YM, Li YC, Guo J, Nie B, Liu YN, Liu WJ. Formononetin inhibits p53 signaling pathway activation to delay cellular senescence and ameliorates diabetic kidney disease. World J Diabetes 2026; 17(2): 112500 [PMID: 41696102 DOI: 10.4239/wjd.v17.i2.112500] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v17/i2/112500.htm |
| Number | Citing Articles |
| 1 |
Xiaotian Gao, Xiaoniao Chen, Luying Qiao, Yingtao Zhang, Xiaoling Liu, Sifan Yang, Yan Zheng, Xun Chen, Xu Wang, Ran Liu, Zheyi Dong, Qian Wang, Quan Hong. Formononetin attenuates early diabetic retinal and renal microvascular injury associated with EGR1/VEGF-related endothelial responses. Journal of Ethnopharmacology 2027; 373 doi: 10.1016/j.jep.2026.122294
|